Headless splice variant acting as dominant negative calcitonin receptor.

[1]  Y. Takei,et al.  Fish calcitonin receptor has novel features. , 2007, General and comparative endocrinology.

[2]  Guangyu Wu,et al.  Regulation of Anterograde Transport of α2-Adrenergic Receptors by the N Termini at Multiple Intracellular Compartments* , 2006, Journal of Biological Chemistry.

[3]  S. Sudo,et al.  Characterization of Novel Splice Variants of LGR7 and LGR8 Reveals That Receptor Signaling Is Mediated by Their Unique Low Density Lipoprotein Class A Modules* , 2006, Journal of Biological Chemistry.

[4]  Philippe Delagrange,et al.  The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization , 2006, The EMBO journal.

[5]  Y. Takei,et al.  Molecular and functional characterization of adrenomedullin receptors in pufferfish. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.

[6]  Guangyu Wu,et al.  The regulatory mechanisms of export trafficking of G protein-coupled receptors. , 2005, Cellular signalling.

[7]  C. Hague,et al.  Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance , 2005, Pharmacological Reviews.

[8]  R. Baron,et al.  The delta e13 isoform of the calcitonin receptor forms a six-transmembrane domain receptor with dominant-negative effects on receptor surface expression and signaling. , 2005, Molecular endocrinology.

[9]  M. Thompson,et al.  The G protein-coupled receptors: Pharmacogenetics and Disease , 2005, Critical reviews in clinical laboratory sciences.

[10]  T. Minegishi,et al.  A splice variant of the human luteinizing hormone (LH) receptor modulates the expression of wild-type human LH receptor. , 2004, Molecular endocrinology.

[11]  Guangyu Wu,et al.  Distinct Pathways for the Trafficking of Angiotensin II and Adrenergic Receptors from the Endoplasmic Reticulum to the Cell Surface , 2003, Journal of Biological Chemistry.

[12]  S. Rees,et al.  GPCR drug discovery through the exploitation of allosteric drug binding sites. , 2002, Receptors & channels.

[13]  P. Sexton,et al.  Molecular pharmacology of the calcitonin receptor. , 2002, Receptors & channels.

[14]  R. Ahn,et al.  Inhibitory activity of alternative splice variants of the bullfrog GnRH receptor-3 on wild-type receptor signaling. , 2001, Endocrinology.

[15]  C. Laplace,et al.  Tissue-specific and Ubiquitous Promoters Direct the Expression of Alternatively Spliced Transcripts from the Calcitonin Receptor Gene* , 2001, The Journal of Biological Chemistry.

[16]  A. Nicot,et al.  Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Sexton,et al.  Functionally different isoforms of the human calcitonin receptor result from alternative splicing of the gene transcript. , 1995, Molecular endocrinology.

[18]  S. Krane,et al.  Cloning and characterization of a mouse brain calcitonin receptor complementary deoxyribonucleic acid and mapping of the calcitonin receptor gene. , 1994, Endocrinology.

[19]  K. Beaumont,et al.  Molecular cloning of two receptors from rat brain with high affinity for salmon calcitonin , 1993, FEBS letters.

[20]  P. Sexton,et al.  Identification of brain isoforms of the rat calcitonin receptor. , 1993, Molecular endocrinology.

[21]  K. Catt,et al.  Molecular cloning and expression of cDNA encoding the murine gonadotropin-releasing hormone receptor. , 1992, The Journal of biological chemistry.

[22]  R. Epand,et al.  Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs. , 1990, Endocrinology.